EMERGENT BIOSOLUT is trading at 9.49 as of the 30th of November 2024, a 0.11 percent down since the beginning of the trading day. The stock's lowest day price was 9.49. EMERGENT BIOSOLUT has 50 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for EMERGENT BIOSOLUT are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. EMERGENT BIOSOLUT's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding EMERGENT BIOSOLUT or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
EMERGENT BIOSOLUT (ER4) is traded on Berlin Exchange in Germany and employs 18 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate EMERGENT BIOSOLUT's market, we take the total number of its shares issued and multiply it by EMERGENT BIOSOLUT's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
EMERGENT BIOSOLUT generates negative cash flow from operations
Check EMERGENT BIOSOLUT Probability Of Bankruptcy
EMERGENT BIOSOLUT Risk Profiles
Although EMERGENT BIOSOLUT's alpha and beta are two of the key measurements used to evaluate EMERGENT BIOSOLUT's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in EMERGENT BIOSOLUT without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Share Portfolio Now
Share Portfolio
Track or share privately all of your investments from the convenience of any device
EMERGENT BIOSOLUT financial ratios help investors to determine whether EMERGENT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EMERGENT with respect to the benefits of owning EMERGENT BIOSOLUT security.